Company Filing History:
Years Active: 2017
Title: The Innovations of Stefan Bauer
Introduction
Stefan Bauer is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly through his innovative work on Toll-like receptors.
Latest Patents
Stefan Bauer holds a patent for "Agonists and antagonists of toll-like receptor (TLR) 13." This invention provides agonists and antagonists of TLR13, which are crucial for developing pharmaceutical agents. The patent outlines TLR13 activating and inhibiting nucleic acids, along with in vitro methods utilizing these nucleic acids.
Career Highlights
Stefan Bauer is associated with Bavarian Nordic A/S, a company known for its focus on developing innovative immunotherapies. His work has positioned him as a key figure in advancing immunological research.
Collaborations
Stefan has collaborated with notable colleagues, including Carsten Juergen Kirschning and Hubertus Hochrein, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Stefan Bauer's contributions to immunology through his patent on TLR13 demonstrate his innovative spirit and commitment to advancing medical science. His work continues to influence the development of new therapeutic agents.